Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 19/20 | 0.82 |
| ▸ | HEXB | P07686 | 5/20 | 0.82 |
| ▸ | HOGA1 | Q86XE5 | 1/20 | 0.54 |
| ▸ | HEXA | P06865 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5020873 | 1.00 | OGA (0.82) | OGAHEXBHOGA1HEXA | |
| SCHEMBL4538051 | 1.00 | OGA (0.82) | OGAHEXBHOGA1HEXA | |
| SCHEMBL12676186 | 0.90 | OGA (1.00) | OGAHEXBHOGA1HEXA | |
| SCHEMBL14240215 | 0.90 | OGA (1.00) | OGAHEXBHOGA1HEXA | |
| SCHEMBL12676107 | 0.90 | OGA (1.00) | OGAHEXBHOGA1HEXA | |
| SCHEMBL1898418 | 0.90 | OGA (1.00) | OGAHEXBHOGA1HEXA | |
| SCHEMBL4562644 | 0.88 | OGA (0.78) | OGAHEXBHOGA1 | |
| SCHEMBL4536649 | 0.88 | OGA (0.78) | OGAHEXBHOGA1 | |
| SCHEMBL4562643 | 0.88 | OGA (0.78) | OGAHEXBHOGA1 | |
| SCHEMBL4537094 | 0.88 | OGA (0.81) | OGAHEXBHOGA1HEXA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8901087-B2 | Selective glycosidase inhibitors and uses thereof | MERCK SHARP & DOHME CORP. (US) | 2014-12-02 | — | — | US | disclosed |
| US-20130296301-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC. (CA) | 2013-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296301-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | ENGASE, OGA, GALE | OGA 2/4885HEXB 40/4885HOGA1 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.